Pharmaceutical composition for treating depression

Abstract

The invention provides a pharmaceutical composition which is prepared from 20-80% of hypericum perforatum extract and the balance of ginkgo leaf extract based on the weight of the pharmaceutical composition. The invention also provides a pharmaceutical preparation containing the pharmaceutical composition. In addition, the invention also provides application of the pharmaceutical composition and the pharmaceutical preparation in preparation of a medicine for treating depression. Pharmaceutical tests show that the pharmaceutical composition provided by the invention has an obvious curative effect on depression, thereby providing a new choice for clinically treating depression.

Description

technical field [0001] The invention belongs to the fields of medicine and pharmacy, and in particular relates to a new pharmaceutical composition for treating depression. Background technique [0002] Depression, also known as depressive disorder, is characterized by significant and persistent (at least 2 weeks or more, or even several years) low mood as the main clinical feature, and is the main type of mood disorder. It can be seen clinically that the mood is not commensurate with the situation. The depression of mood can range from gloomy to distraught, low self-esteem and depression, even pessimistic world-weariness, and there may be suicide attempts or behaviors; even stupor; some cases have obvious anxiety and motor agitation; In severe cases, psychotic symptoms such as hallucinations and delusions may appear. [0003] Depression is a chronic mental illness with high prevalence, high disease burden, high relapse rate, high disability rate, and high suicide rate. Acc...

AI Technical Summary

Problems solved by technology

[0008] Although there are new drugs on the market, it is clear that the treatment methods for depression are far from meeting patients' expectations for efficacy and treatment outcomes

Images